CME Group (CME)
(Delayed Data from NSDQ)
$221.17 USD
-4.02 (-1.79%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $221.16 -0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$221.17 USD
-4.02 (-1.79%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $221.16 -0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth F Momentum F VGM
Zacks News
CME Group (CME) Prices $1.2 Billion Senior Unsecured Notes
by Zacks Equity Research
CME Group's (CME) new issuance speaks volumes for its wise move to capitalize on a low interest rate environment to obtain funds.
Here's Why Bitcoin Is Tumbling Today
by Ryan McQueeney
The price of bitcoin and several other major cryptocurrencies has dropped sharply in the past 24 hours after South Korean exchange Coinrail said it was hacked over the weekend.
Cboe Global May ADV Soft, Global FX Matched Solid, Shares Up
by Zacks Equity Research
Cboe Global's (CBOE) reports total contracts of 152.9 million for May, a decrease of 5.3% year over year. However, Global FX Matched improves 45.3% to nearly $40.9 billion.
Nasdaq (NDAQ) Reports Mixed Volumes for May, Shares Rise
by Zacks Equity Research
Nasdaq's (NDAQ) mixed May volumes rise in U.S. equity options. However, European options and futures show a decline.
CME Group's (CME) May Volume Figures Strong, Shares Rise
by Zacks Equity Research
CME Group's (CME) May volumes reflect double-digit growth across Forex, Interest Rates, Metals, Agriculture and Equity Index products.
6 Reasons Why You Should Hold on to Cboe Global Stock Now
by Zacks Equity Research
Cboe Global Markets (CBOE) remains well-poised for growth on the back of its strong market position and a global reach with potent proprietary products.
Nasdaq Scales 52-Week High: Can it Sustain the Bull Run?
by Zacks Equity Research
Nasdaq's (NDAQ) solid April volumes, improved Q1 performance and strategic initiatives drive stock to hit 52-week high in the last trading session.
7 Reasons Why You Should Retain Nasdaq in Your Portfolio
by Zacks Equity Research
Nasdaq (NDAQ) appears profitable, promising better reward for investors on the back of seven factors.
Cboe Global (CBOE) Beats on Q1 Earnings, Revises Guidance
by Zacks Equity Research
Cboe Global Markets' (CBOE) Q1 rides high on improved revenues, courtesy of the Bats buyouts and segmental trading volume expansion.
Intercontinental Exchange (ICE) Q1 Earnings Top, Rise Y/Y
by Zacks Equity Research
Intercontinental Exchange's (ICE) Q1 rides high on strong performance across trading and clearing as well as data and listings segments alongside higher revenues.
Has CME Group (CME) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Is CME Group Inc. (CME) Outperforming Other Finance Stocks This Year?
CME Group (CME) Q1 Earnings Beat, Revenues Lag Estimates
by Zacks Equity Research
Bottom-line growth along with higher revenues and a record average daily volume drives CME Group's (CME) results in Q1.
CME Group (CME) Q1 Earnings Top Estimates, Revenues Miss
by Zacks Equity Research
Higher average daily volume as well as revenues, along with improved operating income find reflection in CME Group's (CME) Q1 earnings results.
7 Reasons Why Nasdaq (NDAQ) Holds Promise for Investors
by Zacks Equity Research
Riding high on seven factors, Nasdaq (NDAQ) holds potential to generate better returns to investors.
Cboe Global Markets' March Volumes Increase, Shares Gain
by Zacks Equity Research
Cboe Global Markets' (CBOE) March volume raises optimism in the stock among investors, ahead of first-quarter 2018 earnings release.
CME Group's (CME) Q1 Volumes Mark Highest Quarterly ADV
by Zacks Equity Research
CME Group's (CME) ADV in Q1 registers a robust rise across five of six product lines.
Intercontinental Exchange Notches Up Record Volumes in Q1
by Zacks Equity Research
Intercontinental Exchange's (ICE) Q1 record volumes reflect better performance in January as well as February.
Cboe Global Markets (CBOE) Gains on Record February Volumes
by Zacks Equity Research
Cboe Global's (CBOE) February ADV reflects record volumes in VIX futures, VIX options and SPX options plus a record trading in Cboe Options Exchange and Cboe Futures Exchange to name a few.
CME Group Posts Record Volumes for February, Shares Gain
by Zacks Equity Research
CME Group's (CME) record February volumes reflect a rise in ADV across all the six product lines.
Intercontinental Exchange's (ICE) February Volume Rises
by Zacks Equity Research
Intercontinental Exchange's (ICE) trading volume improves in February. We expect its diverse product line and risk management services to drive the same in the near term.
Cboe Global (CBOE) Authorizes Share Buyback Plan Worth $150M
by Zacks Equity Research
Cboe Global (CBOE) authorizes an additional share repurchase program worth $150 million, which is likely to help boost the company's shareholders value and buoy optimism among investors.
Cboe Global (CBOE) Q4 Earnings Miss Estimates, Issues View
by Zacks Equity Research
Cboe Global's (CBOE) Q4 reflects higher revenues, benefit from enactment of the Tax Reform and expanded trading volume, partially offset by increased expenses.
Intercontinental Exchange (ICE) Q4 Earnings Beat & Up Y/Y
by Zacks Equity Research
Intercontinental Exchange's (ICE) Q4 rides on improved top line and reduced expenses.
CME Group (CME) Q4 Earnings Beat Estimates, Revenues Dip Y/Y
by Zacks Equity Research
Although CME Group (CME) outpaces estimates in Q4, its bottom and top-line deterioration and lower trading volume are dampeners.
CME Group (CME) Q4 Earnings Top Estimates, Revenues Down Y/Y
by Zacks Equity Research
Lower average daily volume as well as revenues, along with reduced expenses find reflection in CME Group's (CME) Q4 earnings results.